focus -WSS

focus

author：entertainment 2025-08-04 08:22:36 - browse：5655

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： PhRMA sues HHS over Medicare drug price negotiation

Wikipedia

WSS

4th of July breaks record for highest global temperature ever measured

Pfizer's Covid pill remains 89% effective in final analysis, company says

3 questions for the future of Biden's cancer moonshot

Inside the fall of star MIT scientist David Sabatini

4th of July breaks record for highest global temperature ever measured

PhRMA sues HHS over Medicare drug price negotiation

knowledge

focus

focus

Novavax promises a turnaround & Lilly roils the obesity market

FDA rejects Alnylam's heart disease treatment over insufficient data

Medicare proposal to cover medical devices draws a mixed reaction

Pfizer's Covid pill remains 89% effective in final analysis, company says

In age of alternative facts, a scholarly course on calling out crap

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

23andMe had bad news about my health. I wish a person had delivered it

FDA rejects Alnylam's heart disease treatment over insufficient data

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

When is a doctor not a doctor? Try when patients address women doctors

knowledge

Was Amgen transparent enough on FDA's concern on cancer drug?

When women are denied an abortion, their children fare worse than peers

Community addresses injustice for Long Island mothers

Brain 'hot spot' may explain why African Americans feel greater pain

Chan Zuckerberg Biohub Chicago to focus on inflammation

Community addresses injustice for Long Island mothers

hotspot

Wikipedia

knowledge

entertainment